Congressional disclosures
| Office | Representative (PA-3) |
|---|---|
| Disclosed events | 182 |
| Purchases, all years | 89 |
| Sales | 93 |
| Publicly available | Transaction date | Asset | Action | Owner | Reported amount |
|---|---|---|---|---|---|
| 2026-06-24 | 2026-06-10 | GD | sale | not_indicated | $1,001 - $15,000 |
| 2026-06-24 | 2026-06-10 | INTC | sale | not_indicated | $1,001 - $15,000 |
| 2026-05-15 | 2026-05-11 | AMT | sale | not_indicated | $1,001 - $15,000 |
| 2026-05-15 | 2026-05-07 | INTC | sale | not_indicated | $1,001 - $15,000 |
| 2026-05-15 | 2026-05-07 | PWR | sale | not_indicated | $1,001 - $15,000 |
| 2026-05-15 | 2026-05-07 | TMO | sale | not_indicated | $1,001 - $15,000 |
| 2026-04-20 | 2026-03-24 | MU | sale | not_indicated | $15,001 - $50,000 |
| 2025-12-19 | 2025-11-21 | BABAF | sale | not_indicated | $1,001 - $15,000 |
| 2025-12-19 | 2025-11-21 | AWK | sale | not_indicated | $1,001 - $15,000 |
| 2025-12-19 | 2025-11-21 | APO | sale | not_indicated | $1,001 - $15,000 |
| 2025-12-19 | 2025-11-21 | CVS | sale | not_indicated | $1,001 - $15,000 |
| 2025-12-19 | 2025-11-21 | MSFT | sale | not_indicated | $1,001 - $15,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.